Abeona Therapeutics Inc.
General ticker "ABEO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $297.1M (TTM average)
Abeona Therapeutics Inc. does not follow the US Stock Market performance with the rate: -3.7%.
Estimated limits based on current volatility of 2.2%: low 5.66$, high 5.91$
Factors to consider:
- Total employees count: 84 as of 2023
- Top business risk factors: Regulatory and compliance, Insufficient funding, Manufacturing risks, Pandemic risks, Cybersecurity threats
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.22$, 7.05$]
- 2026-12-31 to 2027-12-31 estimated range: [3.59$, 7.61$]
Financial Metrics affecting the ABEO estimates:
- Positive: with PPE of 5.1 at the end of fiscal year the price was low
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 37.92 > -0.60
- Negative: negative Industry operating income (median)
- Negative: Shareholder equity ratio, % of 72.51 > 64.29
Short-term ABEO quotes
Long-term ABEO plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $3.50MM | $0.00MM | $5.82MM |
| Operating Expenses | $50.63MM | $64.21MM | $95.27MM |
| Operating Income | $-47.13MM | $-64.21MM | $-89.45MM |
| Non-Operating Income | $-7.05MM | $0.48MM | $160.73MM |
| Interest Expense | $0.42MM | $4.21MM | $3.74MM |
| R&D Expense | $31.09MM | $34.36MM | $26.81MM |
| Income(Loss) | $-54.19MM | $-63.73MM | $71.28MM |
| Taxes | $0.00MM | $0.00MM | $0.10MM |
| Net Income(Loss)* | $-54.19MM | $-63.73MM | $71.18MM |
| Stockholders Equity | $14.83MM | $44.03MM | $159.22MM |
| Inventory | $0.00MM | $0.00MM | $5.49MM |
| Assets | $64.00MM | $108.93MM | $219.57MM |
| Operating Cash Flow | $-37.01MM | $-56.02MM | $-76.33MM |
| Capital expenditure | $0.33MM | $2.45MM | $7.97MM |
| Investing Cash Flow | $0.21MM | $-39.24MM | $105.03MM |
| Financing Cash Flow | $37.06MM | $104.14MM | $26.04MM |
| Earnings Per Share** | $-2.53 | $-1.55 | $1.34 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.